Endocyte Stock Price (NASDAQ:ECYT)

Add to My Stocks
$3.18 $0.03 (0.95%) ECYT stock closing price Feb 16, 2018 (Closing)
Prev Close* : $3.15
Market Cap:
Day Low: $3.14
52 Week Low: $1.17
Open: $3.15
Volume: -
Day High: $3.36
52 Week High: $6.55

Latest Stock Market News

Latest Articles

Endocyte News - From Partners

Endocyte Added to NASDAQ Biotechnology Index     by Globe Newswire on Dec 15, 2017
Endocyte Reports Third Quarter Financial Results   by Globe Newswire on Nov 06, 2017
5 ETF Picks for October   by Zacks on Oct 04, 2017

ECYT Stockcharts

View ECYT PE ratio, PS ratio stocks charts and compare with peers.
ECYT Chart
Note: Compare Endocyte stock price history with the index and industry peers.

Endocyte Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Endocyte Returns

(return on equity)

Endocyte Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

ECYT Industry Peers

Company Price Change (%)
Forward Pharma (FWP)3.150.1 (3.08%)
Sierra Oncology (SRRA)2.90.06 (2.03%)
Lantheus Holdings (LNTH)20.550.2 (0.98%)
Sumitomo Chemcl (SOMMY)31.690.19 (0.6%)
Eli Lilly (LLY)78.970.95 (1.22%)
Incyte (INCY)86.030.44 (0.51%)
Pfizer (PFE)36.260.55 (1.54%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Galectin Therapeutics (GALT)4.340.34 (8.5%)
ImmunoGen (IMGN)11.270.62 (5.82%)
ArQule (ARQL)1.720.09 (5.52%)
Nature's Sunshine Products (NATR)11.950.5 (4.37%)
Depomed (DEPO)7.440.28 (3.91%)
MediWound (MDWD)4.350.15 (3.57%)
Redhill Biopharma (RDHL)6.120.19 (3.2%)
Top gainers from Medical-Drugs industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Pacira Pharma (PCRX)30.155.95 (16.48%)
Flexion Therapeutics (FLXN)23.191.39 (5.66%)
Recro Pharma (REPH)8.30.4 (4.6%)
Arrowhead Pharma (ARWR)5.570.26 (4.46%)
Akebia Therapeutics (AKBA)14.140.64 (4.33%)
MOLECULAR TEMPL (MTEM)8.860.37 (4.01%)
Synergy Pharma (SGYP)2.030.08 (3.79%)
Top losers from Medical-Drugs industry
* As of Feb 17, 2018

Endocyte, Inc. Stock News - Partner Headlines

Endocyte Financial Statements

income statement20162015201420132012
Net Sales or Revenues--70.35M64.87M34.68M
Net Income-43.88M-41.26M5.45M-18.03M-17.29M
Total Operating Expense44.78M42.03M65.31M83.2M50.72M
View Endocyte income statement
balance sheet20162015201420132012
Total Assets143.49M178.38M212.8M162.85M214.07M
Total Liabilities6.34M7.03M7.79M74.62M114.5M
Shareholders Equity137.14M171.34M205M88.22M99.57M
View Endocyte balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-1.4M-0.12M-58.16M-41.02M101.06M
Net Cash from (used by) Operating Activities-34.65M-32.21M-42.2M-51.08M89.19M
Increase (Decrease) in Prop Plant And Equipment-0.71M-0.34M-1.49M-0.82M-1.86M
View Endocyte cash flow statement

Endocyte Stock Message Board

An investor needs to spend $3.18 to buy ECYT stock, as the closing Endocyte stock price is $3.18. Endocyte market capitalization is $150.82M and it represents the total market value of ECYT stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Endocyte stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Endocyte is worth a lot, it will most likely be reflected in an inflated Endocyte stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 632,097 shares were traded with a closing stock price of $3.18 as of Feb 16, 2018, as can be seen from Endocyte stock quote. One can view Endocyte stock chart to follow the stock price trend. Endocyte paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of ECYT, view Endocyte stock price history.